Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 62

Sort by

Sort Order Select

Journal Articles

Late Effects: An Evaluation of Contrasting Physical and Psychological Experiences Between Child and Adult Hodgkin Survivors

Shah-Jalal Sarker, PhD FHEA, Gincy Elsa George, Kashfia Chowdhury, MSc, Gill Levitt, MD FRPCh, Judith Kingston, Andrew Lister, John G. Gribben, MD DSc, Ania Korszun, PhD MD FRCPsych

Blood (2014) 124 (21): 1309.

https://doi.org/10.1182/blood.V124.21.1309.1309

Published: 2014

Journal Articles

Psychosocial Factors and Impact Of Cancer In British Long-Term Haematological Cancer Survivors

Ania Korszun, PhD, MD, FRCPsych, Shah-Jalal Sarker, PhD, FHEA, Kashfia Chowdhury, MSc, Charlotte Clark, PhD, CPsychol, Paul Greaves, MD, Rachel Johnson, Judith Kingston, Gill Levitt, MD, FRPCh, Janet Matthews, Peter White, MD, FRCP, FRCPscyh, Andrew Lister, John Gribben, MD, DSc

Blood (2013) 122 (21): 2943.

https://doi.org/10.1182/blood.V122.21.2943.2943

Published: 2013

Journal Articles

Concurrent Follicular Lymphoma At Diagnosis Has a Negative Impact On The Outcome Of Patients With Diffuse Large B Cell Lymphoma

David Wrench, MD, PhD, Hasan Rizvi, MD, Andrew Wilson, Ciaran O'Riain, MD, PhD, Andrew Clear, Janet Matthews, Daniele Laszlo, MD, T. Andrew Lister, MD, John G. Gribben, MD, DSc, FRCP, FMedSci, FRCPath, Maria Calaminici, MD, PhD, Silvia Montoto, MD

Blood (2013) 122 (21): 4260.

https://doi.org/10.1182/blood.V122.21.4260.4260

Published: 2013

Journal Articles

Updated 6 Year Follow-Up Of The PRIMA Study Confirms The Benefit Of 2-Year Rituximab Maintenance In Follicular Lymphoma Patients Responding To Frontline Immunochemotherapy

Blood (2013) 122 (21): 509.

https://doi.org/10.1182/blood.V122.21.509.509

Published: 2013

Journal Articles

EZH2 mutations are frequent and represent an early event in follicular lymphoma

Blood (2013) 122 (18): 3165–3168.

https://doi.org/10.1182/blood-2013-04-496893

Published: 2013

Includes: Supplemental data

Journal Articles

The Relationship of Depression and Anxiety and Impact of Cancer in Long-Term Survivors of Haematological Malignancy.

Ania Korszun, Rachel Johnson, Shah-Jalal Sarker, Chowdhury Kashfia, Charlotte Clark, Paul Greaves, MD, Judith Kingston, Gill Levitt, Janet Matthews, Rebecca Matthews, Matthew Smith, John G Gribben, T. Andrew Lister

Blood (2012) 120 (21): 3174.

https://doi.org/10.1182/blood.V120.21.3174.3174

Published: 2012

Journal Articles

High Incidence of EZH2 Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy

Blood (2012) 120 (21): 545.

https://doi.org/10.1182/blood.V120.21.545.545

Published: 2012

Journal Articles

Involved Field Radiotherapy Versus No Further Treatment in Patients with Clinical Stages IA and IIA Hodgkin Lymphoma and a ‘Negative’ PET Scan After 3 Cycles ABVD. Results of the UK NCRI RAPID Trial

John Radford, Sally Barrington, Nicholas Counsell, Ruth Pettengell, Peter Johnson, Jennie Wimperis, Stewart Coltart, Dominic Culligan, Andrew Lister, Eric Bessell, Anton Kruger, Bilyana Popova, Barry Hancock, Peter Hoskin, Timothy Illidge, Michael O'Doherty

Blood (2012) 120 (21): 547.

https://doi.org/10.1182/blood.V120.21.547.547

Published: 2012

Journal Articles

Whole Genome Sequencing in Sequential Biopsies Reveals the Genetic Evolution of Follicular Lymphoma to Transformed Follicular Lymphoma

Jessica Okosun, MD, Csaba Bödör, PhD, Jun Wang, PhD, Shamzah Araf, MD, Jacek Marzec, PhD, Sameena Iqbal, Janet Matthews, Maria Calaminici, MD, Ciaran O'Riain, MD, PhD, Derville O'Shea, MD, PhD, Emanuela Carlotti, PhD, Andrew Davies, MD, David Wrench, MD, PhD, András Matolcsy, MD, PhD, T. Andrew Lister, MD, John G Gribben, Silvia Montoto, MD, Claude Chelala, PhD, Jude Fitzgibbon, PhD

Blood (2012) 120 (21): 145.

https://doi.org/10.1182/blood.V120.21.145.145

Published: 2012

Journal Articles

The Importance of Age in Prognosis of Follicular Lymphoma: Clinical Features and Life Expectancy of Patients Younger Than 40 Years

Chiara Lobetti-Bodoni, MD, Paola MV Rancoita, PhD, Silvia Montoto, MD, Armando Lopez-Guillermo, MD, Annarita Conconi, MD, Rita Coutinho, MD, Janet Matthews, Silvia Franceschetti, MD, Francesco Bertoni, MD, Franco Cavalli, MD, Michele Ghielmini, MD, Andrew Lister, MD, Emili Montserrat, MD, Emanuele Zucca, MD

Blood (2011) 118 (21): 1593.

https://doi.org/10.1182/blood.V118.21.1593.1593

Published: 2011

Journal Articles

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium

Blood (2011) 117 (26): 7070–7078.

https://doi.org/10.1182/blood-2011-04-345256

Published: 2011

Includes: Supplemental data

Journal Articles

SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma

David Wrench, Pamela Leighton, Christine F. Skibola, Lucia Conde, Jean-Baptiste Cazier, Janet Matthews, Sameena Iqbal, Emanuela Carlotti, Csaba Bödör, Silvia Montoto, Maria Calaminici, John G. Gribben, T. Andrew Lister, Jude Fitzgibbon

Blood (2011) 117 (11): 3147–3150.

https://doi.org/10.1182/blood-2010-10-315382

Published: 2011

Includes: Supplemental data

Journal Articles

A Single-Centre Analysis by Intention to Treat with High Dose Chemotherapy and Autologous Stem Cell Rescue Following Second-Line Treatment In Patients with Hodgkin Lymphoma

Paul Greaves, Andrew Wilson, Janet Matthews, Daniel L P Brown, Silvia Montoto, MD, John G. Gribben, MD, DSc, Andrew Lister, MD

Blood (2010) 116 (21): 2388.

https://doi.org/10.1182/blood.V116.21.2388.2388

Published: 2010

Journal Articles

Prospective Use of a Triple FISH Probe to Predict sMDS/AML Following High Dose Therapy with Autologous Stem Cell Rescue for Lymphoma.

Paul Greaves, Silvia Montoto, MD, Janet Matthews, Andrew Wilson, Daniel L P Brown, Debra Lillington, John G. Gribben, MD, DSc, Andrew Lister, MD

Blood (2010) 116 (21): 3459.

https://doi.org/10.1182/blood.V116.21.3459.3459

Published: 2010

Journal Articles

Updated Results of the PRIMA Study Confirms the Benefit of 2-Years Rituximab Maintenance In Follicular Lymphoma Patients Responding to Immunochemotherapy.

Blood (2010) 116 (21): 1788.

https://doi.org/10.1182/blood.V116.21.1788.1788

Published: 2010

Journal Articles

Tositumomab and I 131 Tositumomab Achieves Complete Remissions Lasting > 10 Years In Patients with Chemotherapy-Refractory Low-Grade and Transformed B-Cell Lymphomas

Mark S. Kaminski, MD, Andrew D. Zelenetz, MD, Oliver W. Press, MD, PhD, Mansoor N. Saleh, MD, John P. Leonard, MD, Louis Fehrenbacher, MD, T. Andrew Lister, MD, Thierry J. Horner, PhD, Vanessa C. Williams, MS, Thomas S. Lin, MD, PhD, Christina Vleisides, DC, Susan J. Knox, MD, PhD, Richard L. Wahl, MD, Julie M. Vose

Blood (2010) 116 (21): 3960.

https://doi.org/10.1182/blood.V116.21.3960.3960

Published: 2010

Journal Articles

An Immunohistochemical Score Based On CD68 and FOXP3 Expression In the Tumour Microenvironment at Diagnosis Defines Prognostic Groups In Both Early and Advanced Stage Classical Hodgkin Lymphoma

Paul Greaves, Andrew James Clear, BSc, David Andrew Owen, Finlay Macdougall, Andrew Wilson, Andrew Lister, MD, Maria Calaminici, John G. Gribben, MD, DSc

Blood (2010) 116 (21): 750.

https://doi.org/10.1182/blood.V116.21.750.750

Published: 2010

Journal Articles

TNFRSF14 and EZH2 Mutations, Chr2p Gain and Copy Number Changes Targeting Genes Whose Proteins Interact with the Microenvironment In Transformed Follicular Lymphoma

David Wrench, Ajanthah Sangaralingam, Hira Tayyib, Myung-Kuk Kang, Ciaran O'Riain, Manu Gupta, Emanuela Carlotti, PhD, BSc, Csaba Bodor, Sameena Iqbal, Tracy Chaplin, Janet Matthews, Andrew James Clear, BSc, Andrew Davies, Silvia Montoto, MD, Maria Calaminici, Bryan D Young, BSc, PhD, John G. Gribben, MD, DSc, Andrew Lister, MD, Jude Fitzgibbon

Blood (2010) 116 (21): 799.

https://doi.org/10.1182/blood.V116.21.799.799

Published: 2010

Journal Articles

Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163 + macrophages within the immediate sprouting microenvironment

Andrew J. Clear, Abigail M. Lee, Maria Calaminici, Alan G. Ramsay, Kelly J. Morris, Simon Hallam, Gavin Kelly, Finlay MacDougall, T. Andrew Lister, John G. Gribben

Blood (2010) 115 (24): 5053–5056.

https://doi.org/10.1182/blood-2009-11-253260

Published: 2010

Journal Articles

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34 − fraction

David C. Taussig, Jacques Vargaftig, Farideh Miraki-Moud, Emmanuel Griessinger, Kirsty Sharrock, Tina Luke, Debra Lillington, Heather Oakervee, Jamie Cavenagh, Samir G. Agrawal, T. Andrew Lister, John G. Gribben, Dominique Bonnet

Blood (2010) 115 (10): 1976–1984.

https://doi.org/10.1182/blood-2009-02-206565

Published: 2010

Includes: Supplemental data

NARROW

Late Effects: An Evaluation of Contrasting Physical and Psychological Experiences Between Child and Adult Hodgkin Survivors

Psychosocial Factors and Impact Of Cancer In British Long-Term Haematological Cancer Survivors

Concurrent Follicular Lymphoma At Diagnosis Has a Negative Impact On The Outcome Of Patients With Diffuse Large B Cell Lymphoma

Updated 6 Year Follow-Up Of The PRIMA Study Confirms The Benefit Of 2-Year Rituximab Maintenance In Follicular Lymphoma Patients Responding To Frontline Immunochemotherapy

EZH2 mutations are frequent and represent an early event in follicular lymphoma

The Relationship of Depression and Anxiety and Impact of Cancer in Long-Term Survivors of Haematological Malignancy.

High Incidence of EZH2 Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy

Involved Field Radiotherapy Versus No Further Treatment in Patients with Clinical Stages IA and IIA Hodgkin Lymphoma and a ‘Negative’ PET Scan After 3 Cycles ABVD. Results of the UK NCRI RAPID Trial

Whole Genome Sequencing in Sequential Biopsies Reveals the Genetic Evolution of Follicular Lymphoma to Transformed Follicular Lymphoma

The Importance of Age in Prognosis of Follicular Lymphoma: Clinical Features and Life Expectancy of Patients Younger Than 40 Years

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium

SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma

A Single-Centre Analysis by Intention to Treat with High Dose Chemotherapy and Autologous Stem Cell Rescue Following Second-Line Treatment In Patients with Hodgkin Lymphoma

Prospective Use of a Triple FISH Probe to Predict sMDS/AML Following High Dose Therapy with Autologous Stem Cell Rescue for Lymphoma.

Updated Results of the PRIMA Study Confirms the Benefit of 2-Years Rituximab Maintenance In Follicular Lymphoma Patients Responding to Immunochemotherapy.

Tositumomab and I 131 Tositumomab Achieves Complete Remissions Lasting > 10 Years In Patients with Chemotherapy-Refractory Low-Grade and Transformed B-Cell Lymphomas

An Immunohistochemical Score Based On CD68 and FOXP3 Expression In the Tumour Microenvironment at Diagnosis Defines Prognostic Groups In Both Early and Advanced Stage Classical Hodgkin Lymphoma

TNFRSF14 and EZH2 Mutations, Chr2p Gain and Copy Number Changes Targeting Genes Whose Proteins Interact with the Microenvironment In Transformed Follicular Lymphoma

Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163 + macrophages within the immediate sprouting microenvironment

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34 − fraction

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only